Dompé names former Amgen exec as CCO

Privately-held Italian drugmaker Dompé has announced the appointment of Shannon Sullivan as is chief commercial officer (CCO), with immediate effect.

Ms Sullivan is a highly accomplished and respected leader in the biopharmaceutical industry, with over 25 years of experience in general management, sales, commercial operations, marketing, and compliance. She has a proven track record of success in launching and growing new products, driving sales growth, and building high-performing teams.

Ms Sullivan joins Dompé from US biotech major Amgen (Nasdaq: AMGN), where she most recently served as vice president, general manager of vasculitis for the Inflammation Business Unit overseeing the team that developed Tavneos (avacopan). Prior to that, she held a variety of senior roles at Amgen, including VP and managing director, Amgen, Australia & New Zealand, and VP, US sales, field excellence and capabilities.